| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | -0.0093 | 0.8 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.8 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | -0.0081 | 0.8 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.0086 | 0.8 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | -0.0082 | 0.8 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.012 | 0.8 |